Mots-C

Price range: $35.00 through $72.00


MOTS-C mitochondrial-derived research peptide available in 10 mg and 40 mg formats with lot-specific analytical documentation. Strictly for laboratory research use only. Not for human or veterinary use.

Order within –h –m –s to ship on Tuesday, November 17.
10:00 AM ET cutoff • In-stock products only

LOT-SPECIFIC TESTING

Verified Test Results


Lot-Specific COA

Parameter Result Specification
Appearance


Good

Meets spec
Purity


99.24%
· Pass

≥ 95%
Net Peptide Content


48.71mg

Reported
Identity


Confirmed

Meets spec
Fentanyl Screen


Not Detected

Pass
Heavy Metals


Not Detected

Pass
Sterility


No Growth

Pass
Lot
MO40-0612
Laboratory
Janoshik Analytical

Results shown apply to the listed product lot. Review the full certificate for complete testing information.

Description

MOTS-C Research Peptide

MOTS-C, short for Mitochondrial Open Reading Frame of the 12S rRNA Type-c, is a 16-amino-acid mitochondrial-derived peptide. It is encoded by a short open reading frame located within the mitochondrial 12S ribosomal RNA region.

East Coast Peptides offers MOTS-C in 10 mg and 40 mg research formats supported by lot-specific analytical documentation. This material is supplied exclusively for controlled laboratory investigation and is not intended for human or veterinary use.

Mitochondrial and Metabolic Research

MOTS-C has been studied as part of the emerging field of mitochondrial-derived peptides—short signaling molecules encoded within mitochondrial DNA. Published research has examined how these peptides participate in communication between mitochondria, the cytoplasm and the nucleus.

An early MOTS-C study used cellular experiments and mouse models to investigate metabolic signaling. Researchers examined pathways involving folate-cycle metabolism, purine biosynthesis, AMP-activated protein kinase, commonly called AMPK, and skeletal-muscle glucose regulation. Outcomes involving insulin sensitivity and high-fat-diet models were obtained primarily from mice and should be understood as preclinical findings.

Separate cell-based research examined MOTS-C under metabolic stress conditions, including glucose restriction and oxidative stress. In those experiments, MOTS-C was observed moving into the nucleus and influencing stress-related nuclear gene expression through an AMPK-associated process.

Exercise-related research has also measured naturally occurring MOTS-C in human muscle and circulation while testing administered MOTS-C in animal models. Findings involving physical performance, metabolic flexibility and age-related physical decline were predominantly produced in mice. Observational changes in naturally occurring human MOTS-C do not establish that administration produces the same outcome in people.

These studies provide useful mechanistic context but do not demonstrate that the East Coast Peptides product produces medical, metabolic, weight-management, performance or longevity outcomes. Researchers should review the current lot documentation and use independently validated methods appropriate to their experimental model.

Selected Research References

Product Information

  • Product: MOTS-C research peptide
  • Length: 16 amino acids
  • Available formats: 10 mg and 40 mg
  • Documentation: Lot-specific analytical results are available through the ECP COA Catalog.
  • Intended application: Laboratory research only

Continue Your Research

Explore evidence-aware compound overviews, comparisons, and laboratory research topics in the ECP Research Blog.

Research Use Notice

This product is sold exclusively for laboratory and research use. Not for human or animal use. It is not intended to diagnose, treat, cure, or prevent any disease. No medical or therapeutic claims are made or implied.

Additional information

Volume

10mg, 40mg

Reviews

There are no reviews yet.

Be the first to review “Mots-C”

Your email address will not be published. Required fields are marked *

This product is currently sold out. Don't worry! Enter your email and we'll notify you when it's available again.